Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 41 , ISSUE 3ESP ( Jun-2013, 2013 ) > List of Articles

REVIEW ARTICLE

Tratamiento de la Oftalmopatía Tiroidea Mediante la Inyección Periocular de Acetónido de Triamcinolona y Dexametasona - Estudio Comparativo

Mona P. Sune, Pradeep G. Sune

Citation Information : Sune MP, Sune PG. Tratamiento de la Oftalmopatía Tiroidea Mediante la Inyección Periocular de Acetónido de Triamcinolona y Dexametasona - Estudio Comparativo. 2013; 41 (3ESP):11-17.

DOI: 10.5005/hos-10101-41304

Published Online: 25-12-2012

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

PDF Share
  1. R. Ebner, M.H. Devoto, DWeil-Treatment of thyroid associated ophthalmopathy with periocular injection of triamcinolone. BJO 2004; 88:1380- 1386
  2. R.A. Goldberg. Orbital steroid injections. BJO 2004; 88:1359-1360
  3. Day MR, Carroll FD. Corticosteroids in the treatment of optic nerve involvement, associated with thyroid dysfunction. Arch Ophthalmol 1968; 79:279-82
  4. Sergott RC, Glaser JS. Grave's opthalmopathy A clinical and immunologic review. Surv ophthalmol 1981;26:1-21 Brown J, Coburn JW, Wigod RA et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Grave's disease. Am J Med 1963;34:786-95
  5. Leone CH. The management of ophthalmic Grave's disease. Ophthalmopathy 1984;91:770-9
  6. Kazim M. Trkel S, Moore S. Treatment of acute Grave's orbitopathy Ophthalmopathy 1991;98:1443-8
  7. Gebertt S. Depot-methyl prednisolone for subconjunctival and retrobulbar injections. Lancet 1961;2:344-5
  8. Garber MI. Methyl prednisolone in the treatment of exophthalmos. Lancet 1966;1:958-60
  9. Trobe JD, Glaser JS Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationle of management. Arch ophthalmol 1978;96:1199-209
  10. Teus MA, Teruel JL, Pascual J, et al. Corticosteroid induced toxic neuropathy. Am J Ophthalmol 1991;112:605-6
  11. Waller SG, Taboada J, O'Connor P. Retrobulbar anaesthesia risk. Ophthalmology 1993;100:506-10
  12. Egbert JE, Schwartz SWalsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J ophthlmol 1996;121:638-42
  13. Koornif L. New insights in the human orbital connective tissue. Arch Ophthalmol 1977;95: 1269-73
  14. Fraunfelder FT, Grsove JA. In: Drug induced ocular side effects, 4th ed. Baltimore: Williams & Wilkins, 1996:323-8
  15. Bhisitkul RB, Lee OT, Wong J, Pereira DD, Porco TC. Neuroprotective effect of triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal haemorrhage. Invest Ophthalmol Vis Sci.2008 April 17.
  16. Brain R. Cortisone in exophtalmos, report on a therapeutic trial of cortisone and corticotrophin (ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955;1:6-9.
  17. Brown J, Coburn JW, Wigod RA, et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;34:786-95.
  18. Werner SC. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1966;1:1004-7.
  19. Day MR, Carroll FD. Corticosteroids in the tratment of optic nerve involvement, associated with thyroid dysfunction. Arch Ophthalmol 1968; 79:279-82.
  20. Fiebel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974; 78:800-5.
  21. Apers RCL, Oosterhuis JA, Goslings BM, et al. Prednisone treatment in endocrine opthalmopathy. Mod Probl Ophthalmol 1975; 14:414- 2022 Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984;5:200-20. 23 McConahey WM. Medical therapy. In: Gorman CA, Waller RR, Dyer JA, eds. In: The eye and orbit in thyroid disease. New York: Raven Press, 1984:317-24.
  22. Nagayama Y, Izumi M, Kiriyama T, et al. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisone pulse therapy. Acta Endocrinol 1987;116:513-18.
  23. Kendall-Taylor P, Combie AL, Stephenson AM, et al. Intraveous methylprednisone in the tratment of Graves' opthalmopathy. BMJ 1988; 297:1547- 78.
  24. Bartalena L, Marcocci C, Bogazzi F, et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321:1349-52.
  25. Hiromatsu Y, Tanaka K, Sato M, et al. Intravenous methylprednisone pulse therapy for Graves' ophthalmopathy. Endocr J 1993; 40:63-72. 28 Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273:808-12. 29 Della Casa F. Zur Therapie des malignen Exophthlmus. Ophthalmologica 1970;161:145-51.
  26. Cant JS. The assessment and treatment of endocrine exophthalmos. Proc Roy Soc Med 1970;63:783-6.
  27. Ivy HK. Medical aproach to ophthalmopathy of Graves' disease. Mayo Clin Proc 1972;47:980-5.
  28. Thomas ID, Hart JK. Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy. Med J Aust 1974; 2:484-7.
  29. Kramar P. Manegement of eye changes of Graves' disease. Surv Ophthalmol 1974; 18:369-82.
  30. Marcocci C, Bartalena L, Panicucci M, et al. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study. Clin Endocrinol 1987; 27:33-42.
  31. Huber A. Ocular motility in Graves' disease. Neuroophthalmology 1984; 4:227-36.
  32. Feibel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974;78:800-5. 39 Jordan DC, Flood JG, Lapostata M, et al. Normal reference laboratory values. N Eng J Med 1992; 327:718-24.
  33. Goodman AG, Gilman LS. Adrenocortical steroids and their synthetic analogs. In: The pharmacological basis of therapeutics. 9th ed. Chapter 59. New York: McGraw-Hill, 1996:1465-76.
  34. Koorneef L. Orbital septa: anatomy and function. Ophthalmology 1979;86:876-80.
  35. Waller SG, Taboada J, O'Connor P. Retrobulbar anesthesia risk. Ophthalmology 1993;100:506- 10.
  36. Wearne MJ, Flaxel C h J, Gray P, et al. Vitreoretinal surgery after inadvertent globe penetration during local ocular anesthesia. Ophthalmology 1998;105:371-644
  37. Gomez-Ulla F, Gonzales F, y Ruiz-Fraga C, Unintentional intraocular injection of corticosteroids. Acta Ophthalmol 1993;71:419-21.
  38. Bullock JD, Warwar RE, Green R. Ocular explosions from periocular anesthetic injections. Ophthalmology 1999; 106:2341-53.
  39. Lam DSCS, Law RWK, Leung ATS, et al. Intraorbital needle fragment: a rare complication of retrobulbar injection. Arch Ophthalmol 1999; 117:1089-90.
  40. Droste PJ, Ellis FD, Sondhi N, et al. Linear subcutaneous fat atrophy after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol 1988; 105:65-9.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.